|
| 36170795 | Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms. | Blood Adv | 2023 |
| 37572755 | The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT. | J Allergy Clin Immunol Pract | 2023 |
| 37244441 | Anaphylaxis: Bench to Bedside. | J Allergy Clin Immunol Pract | 2023 |
| 37230384 | Extrinsic and Intrinsic Modulators of Anaphylaxis. | J Allergy Clin Immunol Pract | 2023 |
| 36997122 | sCD14 and Intestinal Fatty Acid Binding Protein Are Elevated in the Serum of Patients With Idiopathic Anaphylaxis. | J Allergy Clin Immunol Pract | 2023 |
| 36693538 | An Atypical Case of Hymenoptera Venom Anaphylaxis. | J Allergy Clin Immunol Pract | 2023 |
| 36581075 | Hematopoietic KIT D816Y mutation presenting as in utero aggressive systemic mastocytosis with response to midostaurin. | J Allergy Clin Immunol Pract | 2023 |
| 36873731 | Assessment of low immunoglobulin levels and clinical manifestations in patients with mastocytosis. | J Allergy Clin Immunol Glob | 2023 |
| 36759089 | Reply to "MRGPRX2: AÂ novel biomarker in mastocytosis?" | J Allergy Clin Immunol Pract | 2023 |
| 36272720 | Diversity, Equity, and Inclusion: A Decade of Progress? | J Allergy Clin Immunol Pract | 2023 |
| 34425177 | Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis. | J Allergy Clin Immunol | 2022 |
| 35342031 | Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice. | J Allergy Clin Immunol Pract | 2022 |
| 35724950 | Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium. | J Allergy Clin Immunol Pract | 2022 |
| 35724949 | Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group. | J Allergy Clin Immunol Pract | 2022 |
| 35724948 | Proposed European Competence Network on Mastocytosis-American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis. | J Allergy Clin Immunol Pract | 2022 |
| 35568301 | Acute increases in total serum tryptase unassociated with hemodynamic instability in diffuse cutaneous mastocytosis. | Ann Allergy Asthma Immunol | 2022 |
| 35753512 | Clinical exome sequencing of 1000 families with complex immune phenotypes: Toward comprehensive genomic evaluations. | J Allergy Clin Immunol | 2022 |
| 35623575 | Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium. | J Allergy Clin Immunol Pract | 2022 |
| 35283331 | Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group. | J Allergy Clin Immunol Pract | 2022 |
| 34374078 | Decoding the intricacies of the mast cell compartment. | Br J Haematol | 2022 |
| 33220353 | A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis. | J Allergy Clin Immunol | 2021 |
| 33593685 | Urticaria Pigmentosa in a Child: Special Considerations for Vaccines, Dietary Concerns, and Other Management. | J Allergy Clin Immunol Pract | 2021 |
| 33806685 | Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021. | Int J Mol Sci | 2021 |
| 33831618 | COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM). | J Allergy Clin Immunol Pract | 2021 |
| 33745886 | Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference. | J Allergy Clin Immunol | 2021 |
| 34901755 | Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal. | Hemasphere | 2021 |
| 34400315 | Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond. | Ann Allergy Asthma Immunol | 2021 |
| 34182161 | Expression of MRGPRX2 in skin mast cells of patients with maculopapular cutaneous mastocytosis. | J Allergy Clin Immunol Pract | 2021 |
| 34004280 | Children with flushing and diarrhea: Is it mast cell activation? | Ann Allergy Asthma Immunol | 2021 |
| 34166845 | Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review. | J Allergy Clin Immunol Pract | 2021 |
| 30948489 | Oncogenic D816V-KIT signaling in mast cells causes persistent IL-6 production. | Haematologica | 2020 |
| 31513910 | Idiopathic anaphylaxis yardstick: Practical recommendations for clinical practice. | Ann Allergy Asthma Immunol | 2020 |
| 30528617 | Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: AÂ Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology. | J Allergy Clin Immunol | 2019 |
| 30149096 | Twelve-year follow-up of omalizumab therapy for anaphylaxis in 2 patients with systemic mastocytosis. | J Allergy Clin Immunol Pract | 2019 |
| 31476322 | AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management. | J Allergy Clin Immunol | 2019 |
| 30828864 | Management of a neonate with diffuse cutaneous mastocytosis: Case report and literature review. | Pediatr Dermatol | 2019 |
| 31056447 | Maculopapular Cutaneous Mastocytosis in a Diverse Population. | J Allergy Clin Immunol Pract | 2019 |
| 30961837 | Insect Sting Anaphylaxis-Or Mastocytosis-Or Something Else? | J Allergy Clin Immunol Pract | 2019 |
| 31102699 | GATA-2-deficient mast cells limit IgE-mediated immediate hypersensitivity reactions in human subjects. | J Allergy Clin Immunol | 2019 |
| 30476213 | Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources. | Nucleic Acids Res | 2019 |
| 30338538 | American Academy of Allergy, Asthma and Immunology response to the EAACI/GA<sup>2</sup> LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of Urticaria 2017 revision. | Allergy | 2019 |
| 28629749 | A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis. | J Allergy Clin Immunol | 2018 |
| 29928922 | Mast cell activation syndrome: Importance of consensus criteria and call for research. | J Allergy Clin Immunol | 2018 |
| 30007457 | Pediatric Expression of Mast Cell Activation Disorders. | Immunol Allergy Clin North Am | 2018 |
| 30488427 | Detection of KIT D816V in peripheral blood of children with manifestations of cutaneous mastocytosis suggests systemic disease. | Br J Haematol | 2018 |
| 29033257 | Chromogranin A is not a biomarker of mastocytosis. | J Allergy Clin Immunol Pract | 2018 |
| 29161766 | Identification of alpha-gal sensitivity in patients with a diagnosis of idiopathic anaphylaxis. | Allergy | 2018 |
| 26797792 | Development and validation of the mastocytosis quality of life questionnaire: MC-QoL. | Allergy | 2016 |
| 26476479 | Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology. | J Allergy Clin Immunol | 2016 |
| 25429914 | Abnormal bone marrow histopathology in paediatric mastocytosis. | Br J Haematol | 2015 |